Stallergenes Greer USA
A leader in allergen immunotherapy (AIT), Stallergenes Greer has been present in the United States since 1904.
Headquartered in London, United Kingdom, with locations in Lenoir, North Carolina and San Diego, California, Stallergenes Greer’s business in the United States is part of a leading global biopharmaceutical company specialising in the development and commercialisation of allergy immunotherapy (AIT) products and services for use in the diagnosis and treatment of allergies.
In the United States, we provide a broad range of allergen immunotherapy and diagnostic solutions for both human and veterinary use that make Stallergenes Greer an essential player in the American market.
Every day, our 357 employees are committed to fulfilling our purpose: enabling precision medicine to improve life for people with allergies.
Stallergenes Greer's manufacturing facilities in Lenoir